Schold Jesse D, Meier-Kriesche Herwig-Ulf
Division of Nephrology, Hypertension, and Transplantation, Department of Medicine, College of Medicine, University of Florida, PO Box 100224, Gainesville, FL, USA.
Clin J Am Soc Nephrol. 2006 May;1(3):532-8. doi: 10.2215/CJN.01130905. Epub 2006 Feb 8.
Renal transplantation has been established as a life-saving procedure for patients with ESRD. Deceased donor kidneys convey variable life expectancies for recipients. However, limited information is available to guide patients and patient advocates concerning the appropriateness to list for expanded criteria donations (ECD). Half-lives for wait-listed transplant candidates were estimated from the time of ESRD onset on the basis of recipient age, primary diagnosis, and organ quality using survival models. In addition, we evaluated the likelihood of candidates' receiving a transplant on the basis of age and other characteristics by duration of waiting time. Older patients (65+) had longer life expectancy when they accepted an ECD within 2 yr of ESRD onset (5.6 yr) compared with waiting for a standard kidney (5.3 yr) or a living donation (5.5 yr) after 4 yr of dialysis. Conversely, younger recipients (18 to 39 yr) had longer life expectancy with a living donation (27.6 yr) or standard kidney (26.4 yr) after 4 yr on dialysis compared with an ECD after 2 yr of dialysis (17.6 yr). Increased candidate age was associated with the likelihood of not receiving a transplant during the period on the waiting list as a result of mortality and separately related to morbidity and delisting. Older and frailer transplant candidates benefit from accepting lower quality organs early after ESRD, whereas younger and healthier patients benefit from receiving higher quality organs even with longer dialysis exposure. These findings are important for transplant candidates and advocates decision-making and for potential further implementation in allocation policy.
肾移植已成为终末期肾病(ESRD)患者的一种挽救生命的治疗方法。已故供体肾脏给受者带来的预期寿命各不相同。然而,关于指导患者及患者权益倡导者评估列入扩大标准供体(ECD)捐献名单的适宜性的信息有限。根据受者年龄、初始诊断和器官质量,利用生存模型从ESRD发病时间开始估算等待移植候选人的半衰期。此外,我们根据等待时间的长短,评估了候选人基于年龄和其他特征接受移植的可能性。与在透析4年后等待标准肾脏(5.3年)或活体捐献肾脏(5.5年)相比,老年患者(65岁及以上)在ESRD发病后2年内接受ECD的预期寿命更长(5.6年)。相反,与透析2年后接受ECD(17.6年)相比,年轻受者(18至39岁)在透析4年后接受活体捐献肾脏(27.6年)或标准肾脏(26.4年)的预期寿命更长。等待名单上候选人年龄的增加与因死亡率而未在等待期间接受移植以及分别与发病率和从等待名单上除名相关。年龄较大且身体较弱的移植候选人在ESRD发病后尽早接受质量较低的器官会受益,而年轻且健康的患者即使透析时间较长,接受质量较高的器官也会受益。这些发现对于移植候选人及其权益倡导者的决策以及分配政策中可能的进一步实施都很重要。